Hey all, I'm not a biotech guy at all, so excuse the ignorance, but ive been watching this since IPO (Stupidly never bought in). In regards to NoNo, my understanding is they will be first to market but have deficiencies that AGN-007 doesnt have, is that correct? And assuming trails are successful etc, when they both eventually hit the market, will AGN-007 make NoNo obsolete, or will they share the market?
Thanks in advance
Hey all, I'm not a biotech guy at all, so excuse the ignorance,...
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
75.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $96.06M | |||
| Open | High | Low | Value | Volume |
| 76.0¢ | 76.0¢ | 74.3¢ | $107.9K | 143.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6522 | 75.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 77.0¢ | 11047 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| AGN (ASX) Chart |